Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Filings indexed 423 across all filing types
Latest filing 2023-07-27 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges (BSE and NSE) regarding the schedule of an Investors/Analysts Meet on 2nd August 2023. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events and information. The document explicitly states it is an intimation about the schedule of a meeting and does not contain any financial data, report content, or detailed presentation. The length is only 2142 characters, which is quite short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an upcoming investor meeting and does not fit into more specific categories like Investor Presentation or Call Transcript, which would contain substantive content.
2023-07-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates and the consequent stop transfer of shares until duplicate certificates are issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3). The content is an announcement about share certificate status and administrative action, not a financial report, audit, management discussion, or any other detailed report type. It does not contain financial data or detailed report content but is a regulatory notification about share certificate loss and stop transfer. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-27 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates due to loss or misplacement by shareholders. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate issuance and compliance. The content is an intimation or notification about a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or meeting materials. The document is a regulatory compliance announcement informing the exchanges about the issuance of duplicate share certificates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The document does not contain any financial data, detailed presentations, or reports. It is an announcement of a meeting schedule rather than the meeting materials or a financial report. The document length is only 2123 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-21 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is an intimation regarding the loss of share certificates and the stop transfer of those shares as per Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is addressed to stock exchanges and details specific share certificate numbers and folio numbers where stop transfer has been marked until duplicate certificates are issued. This is a regulatory compliance announcement related to share transfer restrictions due to lost certificates, not a financial report, management change, or voting result. It does not contain financial data or detailed report content but is a formal notification to the exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-19 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of a share certificate and the consequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and transfer restrictions. The content is an announcement of a specific event related to share certificates and does not contain financial data, management discussion, or report publication. It is not a report or financial statement but a regulatory compliance notification about share transfer status due to lost certificates. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-07-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.